Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Erin Sparrow"'
Autor:
Tazio Vanni, Beatriz C. Thomé, Erin Sparrow, Martin Friede, Christopher B. Fox, Anna Marie Beckmann, Chuong Huynh, Gabriella Mondini, Daniela H. Silveira, Juliana Y. K. Viscondi, Patrícia Emilia Braga, Anderson da Silva, Maria da Graça Salomão, Roberta O. Piorelli, Joane P. Santos, Vera Lúcia Gattás, Maria Beatriz B. Lucchesi, Mayra M. M. de Oliveira, Marcelo E. Koike, Esper G. Kallas, Lucia M. A. Campos, Eduardo B. Coelho, Marilda A. M. Siqueira, Cristiana C. Garcia, Milene Dias Miranda, Terezinha M. Paiva, Maria do Carmo S. T. Timenetsky, Eduardo A. Adami, Milena A. Akamatsu, Paulo Lee Ho, Alexander R. Precioso
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
The emergence of potentially pandemic viruses has resulted in preparedness efforts to develop candidate vaccines and adjuvant formulations. We evaluated the dose-sparing effect and safety of two distinct squalene-based oil-in-water adjuvant emulsion
Externí odkaz:
https://doaj.org/article/5ee6497bf41b443da8fab583e15ed70d
Autor:
Goran Stevanovic, Aleksandar Obradovic, Snezana Ristic, Dragan Petrovic, Branislava Milenkovic, Danilo Mitrovic, Svetlana Filipovic Vignjevic, Katarina Ilic, Vera Stoiljkovic, Lidija Lavadinovic, Mijomir Pelemis, Svetlana Petrovic, Ana Vidmanic, Olga Popovic, Natasa Eremic, Erin Sparrow, Guido Torelli, Muriel Socquet, Renée Holt, Yordanka Ilieva-Borisova, Yuxiao Tang, Francesco Berlanda Scorza, Jorge Flores, Niraj Rathi
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 8 (2020)
This study was a phase III, multicenter, double-blind, randomized, placebo-controlled trial to evaluate the safety and immunogenicity of a seasonal trivalent split, inactivated influenza vaccine (TIV) in healthy Serbian adults between the ages of 18
Externí odkaz:
https://doaj.org/article/1fb3d26d2cea44f3b3dcf12284b2c3bb
Autor:
Goran Stevanovic, Lidija Lavadinovic, Svetlana Filipovic Vignjevic, Renée Holt, Katarina Ilic, Francesco Berlanda Scorza, Erin Sparrow, Vera Stoiljkovic, Guido Torelli, Tamra Madenwald, Muriel Socquet, Aleksandra Barac, Yordanka Ilieva-Borisova, Mijomir Pelemis, Jorge Flores
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 3, Pp 579-586 (2018)
This study was a phase I double-blind, randomized, placebo-controlled trial to evaluate the safety and immunogenicity of a Serbian-produced seasonal trivalent split, inactivated influenza vaccine in healthy adults. The vaccine was manufactured in egg
Externí odkaz:
https://doaj.org/article/7fa15ca9a5884c72a51c286a6f94d75e
Autor:
Erin Sparrow, Mateusz Hasso-Agopsowicz, David C. Kaslow, Kavita Singh, Raman Rao, Moredreck Chibi, Lindiwe E. Makubalo, John C. Reeder, Gagandeep Kang, Ruth A. Karron, Alejandro Cravioto, Claudio F. Lanata, Martin Friede, Bernadette Abela-Ridder, Anthony W. Solomon, Daniel Argaw Dagne, Birgitte Giersing
Publikováno v:
Frontiers in Tropical Diseases. 3
The mRNA vaccine technology platform may enable rapid response to some emerging infectious diseases (EIDs), as demonstrated through the COVID-19 pandemic. Beyond the role it could play in future EID response, mRNA technology also could have an import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d54061c6c098942b8fb3e173a348370
https://doi.org/10.3389/fitd.2022.844039
https://doi.org/10.3389/fitd.2022.844039
Autor:
James G. Wood, Siranda Torvaldsen, Ann Moen, Christopher Chadwick, Erin Sparrow, Anthony T. Newall, Guido Torelli
Publikováno v:
Vaccine
Highlights • Annual seasonal vaccine production capacity is estimated at 1.48 billion doses. • Best-case annual production for pandemic vaccine is estimated at 8.31 billion doses. • Modest growth in pandemic influenza vaccine production capacit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d08d9eb8e902231bbd568075fac50e8
https://doi.org/10.1016/j.vaccine.2020.12.018
https://doi.org/10.1016/j.vaccine.2020.12.018
Autor:
Erin Sparrow, Ifedayo Adetifa, Nathorn Chaiyakunapruk, Thomas Cherian, Deshayne B. Fell, Barney S. Graham, Bruce Innis, David C. Kaslow, Ruth A. Karron, Harish Nair, Kathleen M. Neuzil, Samir Saha, Peter G. Smith, Padmini Srikantiah, Fred Were, Heather J. Zar, Daniel Feikin
World Health Organization (WHO) preferred product characteristics describe preferences for product attributes that would help optimize value and use to address global public health needs, with a particular focus on low- and middle-income countries. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452ecc5c5f7cf5fc0e1fe993b8036150
https://researchonline.lshtm.ac.uk/id/eprint/4665861/1/1-s2.0-S0264410X22001864-main.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4665861/1/1-s2.0-S0264410X22001864-main.pdf
Publikováno v:
Vaccine. 40(33)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d61dd33a922d475c32f75834e58a15b
https://pubmed.ncbi.nlm.nih.gov/35810059
https://pubmed.ncbi.nlm.nih.gov/35810059
Autor:
Marie Paule Kieny, Bernadette Abela-Ridder, Anthony T. Newall, James G. Wood, Mohamud Sheikh, Siranda Torvaldsen, Erin Sparrow
Publikováno v:
Vaccine. 37:A132-A139
Despite successful control in many parts of the world, rabies virus continues to result in tens of thousands of deaths each year. Death from rabies can be prevented by timely and appropriate post exposure prophylaxis including wound cleaning and admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de24283186f9f091b4d8d7885005f96f
https://doi.org/10.1016/j.vaccine.2018.11.004
https://doi.org/10.1016/j.vaccine.2018.11.004
Autor:
Rekstin Ar, E. V. Krutikova, Larisa Rudenko, Irina Kiseleva, Vera Krivitskaya, Erin Sparrow, Donina Sa, Ekaterina Stepanova, Maria Pisareva, Guido Torelli
Publikováno v:
BioMed Research International, Vol 2018 (2018)
Background.Currently, two genetic lineages of influenza B virus, B/Victoria and B/Yamagata, are cocirculating in humans in various countries. This situation has raised a question regarding the possibility of cross-protection between B components of l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1588510c9453962d591841f5c7eb7a5c
https://doi.org/10.1155/2018/9695628
https://doi.org/10.1155/2018/9695628
Publikováno v:
Vaccine
McLean, K, Goldin, S, Nannei, C, Sparrow, E & Torelli, G 2016, ' The 2015 global production capacity of seasonal and pandemic influenza vaccine ', Vaccine, vol. 34, no. 45, pp. 5410-5413 . https://doi.org/10.1016/j.vaccine.2016.08.019
McLean, K, Goldin, S, Nannei, C, Sparrow, E & Torelli, G 2016, ' The 2015 global production capacity of seasonal and pandemic influenza vaccine ', Vaccine, vol. 34, no. 45, pp. 5410-5413 . https://doi.org/10.1016/j.vaccine.2016.08.019
Highlights • Significant growth reported in influenza vaccine production capacity since 2006. • Seasonal influenza vaccine production capacity has reduced since 2013. • Pandemic influenza vaccine production capacity is at its highest recorded l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::246b34b5645cd8fade1bd98c42b372d5